As reported in our previous study, the CpG island located at the promoter region of DLX7 (CpG island 2 in Fig. 1b) was methylated in CML patients and K562 cell line, and was associated with DLX7 expression [26]. The gene discussed is DLX4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.